Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23515315 | 1.00 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL25735228 | 1.00 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL27542782 | 0.95 | CTSK (0.51) | CTSKCTSS | |
| Hydrochloric Acid SCHEMBL27541055 | 0.93 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28166713 | 0.93 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28470420 | 0.93 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28879680 | 0.93 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL18122641 | 0.93 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL29650147 | 0.92 | CTSK (0.49) | CTSKCTSS | |
| SCHEMBL18644348 | 0.90 | CTSK (0.56) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024044744-A2 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2022140520-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS, INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2020142557-A1 | IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION | BIOMEA FUSION, LLC (US) | 2020-07-09 | — | — | WO | disclosed |
| EP-2524917-B1 | FUSED PYRIDINE DERIVATIVES | SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD (CN) | 2018-06-27 | — | — | EP | disclosed |
| US-9029359-B2 | Heteroaryl Btk inhibitors | BIOGEN IDEC MA, INC. (US) | 2015-05-12 | — | — | US | disclosed |